Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | NKG2D CAR T-cells & soluble NKG2D ligands

Antonio Pérez-Martínez • 2 Oct 2020
EBMT 2020
General CAR-T

Antonio Pérez-Martínez, MD, PhD, Hospital Universitario La Paz, Madrid, Spain, discusses his talk from the 2020 EBMT meeting outlining NKG2D CAR T-cells and how they are not affected by soluble NKG2D ligands. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Antonio Pérez-Martínez

1:33
Novel dual-targeting CD19/22 CAR-T therapy in relapsed ALL
Antonio Pérez-Martínez • 23 Apr 2023
1:28
Efficacy of CD45RA- T-cell infusion to treat infections in immunocompromised patients and EBV-LPDs
Antonio Pérez-Martínez • 23 Apr 2023
1:09
Outcomes following haploidentical & cord blood transplantation in pediatric patients with AML
Antonio Pérez-Martínez • 23 Apr 2023
2:02
Safety and efficacy of CD45RA+-depleted DLI in pediatric stem cell transplant recipients
Antonio Pérez-Martínez • 23 Apr 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals